Nexalin Technology Inc (NXL) Stock Price, Quote & News

Company Profile

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injur...

Industry: Medical Devices

Sector: Healthcare

Phone: 832 260 0222

Website: www.nexalin.com

Address:

1776 Yorktown, Suite 550, Houston, United States

CapitalistInvestor Oct. 11 at 7:38 PM

$NXL Make sure you have ticker VRME on ur watch list. VRME is a verified sleeper. Cash flow ✅ Hidden treasury ✅ Technical breakout loading ✅ Bottomed chart. Minimal downside. Max leverage.

0 · Reply

davis8uni Oct. 11 at 12:33 PM

$BULL $ATON $NXL $XBIO $BIAF

0 · Reply

Modsiu Oct. 11 at 1:05 AM

$SPRB $ZNB $ONMD $BNAI $NXL

0 · Reply

Turgor359 Oct. 10 at 4:03 PM

$NXL 🗑️ will be in the 1-1.1 range next week, the cure for cancer donation business way more profitable than actually curing it, I doubt this runs till early 2026

0 · Reply

trading_momentum_x Oct. 10 at 3:57 PM

$APLT looks good to me, this one is getting a nice breakout and seeing some momentum here and leaning bullish on it. $NXL looks like it is stuck in chop here, this one is a clear avoid to me here.

0 · Reply

JL_TradeZ Oct. 10 at 3:20 PM

$NXL 3.8 nhod 🔥

1 · Reply

Goldwave9 Oct. 10 at 2:17 PM

$NXL not really in the position I would prefer. I think it will have to go lower before it can make big gains. in other words, looking good on the 15 but not so good on the hour.

0 · Reply

Porrotu Oct. 10 at 1:49 PM

$NXL Short at $1.50, held overnight (risky :| ), but paying off. Stop loss at $1.50 now

0 · Reply

davis8uni Oct. 10 at 11:18 AM

$BULL $ATON $NXL $XBIO $BIAF

1 · Reply

Superchuck01 Oct. 9 at 6:29 PM

$NXL Got out yesterday at $2.00 Made mine… Hasta la vista baby…

0 · Reply

Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

Oct 8, 2025, 2:45 PM EDT - 3 days ago

Why Is Micro-Cap Stock Nexalin Technology Rallying On Wednesday?

Oct 8, 2025, 8:30 AM EDT - 3 days ago

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer's Disease with Gen-2 SYNC Neurostimulation Device

Sep 25, 2025, 8:30 AM EDT - 16 days ago

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology

Aug 25, 2025, 9:00 AM EDT - 6 weeks ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on September 9

Aug 1, 2025, 8:30 AM EDT - 2 months ago

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives

May 28, 2025, 10:00 AM EDT - 4 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3

May 13, 2025, 8:30 AM EDT - 5 months ago

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data

May 6, 2025, 2:40 PM EDT - 5 months ago

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

May 5, 2025, 8:20 AM EDT - 5 months ago

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

May 1, 2025, 10:30 AM EDT - 5 months ago

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

Apr 24, 2025, 9:00 AM EDT - 6 months ago

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

Apr 23, 2025, 9:15 AM EDT - 6 months ago

Nexalin Technology Announces Completion of Phases One Through Five of its Virtual Clinic and Digital Ecosystem for HALO™ Clinical Research and Patient Management

Apr 21, 2025, 8:00 AM EDT - 6 months ago

Nexalin Technology Expresses Strong Support for Health Tech Investment Act to Advance Medicare Reimbursement for AI-Enabled Devices

Apr 14, 2025, 12:30 PM EDT - 6 months ago

Nexalin Technology Secures USPTO Patent for Deep Intracranial Frequency Stimulation (DIFS™) Technology in Treating Substance Use Disorders

Apr 2, 2025, 8:30 AM EDT - 6 months ago

Nexalin Technology Enrolls First Patients and Advances Toward Treatment in UCSD Clinical Trial

Mar 26, 2025, 8:30 AM EDT - 7 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on April 3

Mar 3, 2025, 8:30 AM EST - 7 months ago

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders

Feb 28, 2025, 8:30 AM EST - 8 months ago

Nexalin Technology Announces Initiation of Patient Recruitment for UCSD's TBI & PTSD Clinical Study Following IRB Approval

Feb 26, 2025, 8:30 AM EST - 8 months ago

Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board

Feb 18, 2025, 8:30 AM EST - 8 months ago

Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment

Feb 10, 2025, 9:00 AM EST - 8 months ago

Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition

Feb 3, 2025, 8:30 AM EST - 8 months ago

Nexalin's Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study

Jan 23, 2025, 11:00 AM EST - 9 months ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session, Today, January 23

Dec 23, 2024, 10:00 AM EST - 10 months ago

Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic

Nov 26, 2024, 10:00 AM EST - 11 months ago

New Peer-Reviewed Publication Validates Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market

Nov 1, 2024, 2:00 PM EDT - 1 year ago

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on November 5th

Nov 1, 2024, 10:34 AM EDT - 1 year ago

Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements

Nov 1, 2024, 9:00 AM EDT - 1 year ago

LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

LOBO

Oct 28, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

CLDI

Oct 22, 2024, 2:15 PM EDT - 1 year ago

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA

Oct 17, 2024, 8:30 AM EDT - 1 year ago

New Study Shows Nexalin's Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer's Patients

Oct 14, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs

Sep 5, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment

Jul 26, 2024, 9:55 AM EDT - 1 year ago

Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

LOBO

Jul 18, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery

Jul 1, 2024, 2:45 PM EDT - 1 year ago

Nexalin Technology Announces Closing of $5.2 Million Public Offering

Jun 27, 2024, 9:15 PM EDT - 1 year ago

Nexalin Technology Announces Pricing of $5.2 Million Public Offering

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer's and Dementia

Jun 14, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

VNRX

Jun 13, 2024, 3:00 PM EDT - 1 year ago

Nexalin Technology Announces Regulatory Approval to Sell Nexalin's Gen-2, 15 mA Neurostimulation Device by the Brazilian Health Regulatory Agency (Anvisa)

Jun 4, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology to Present at the Spring MicroCap Rodeo Conference on June 6th

Jun 3, 2024, 8:30 AM EDT - 1 year ago

FDA Provides Feedback and Reaches Consensus on Nexalin's Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device

May 22, 2024, 8:30 AM EDT - 1 year ago

Nexalin America Selected to Join the National Traumatic Brain Injury Registry Coalition to Propel TBI Awareness and Research Efforts

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology CEO Provides Letter to Shareholders

Apr 4, 2024, 1:00 PM EDT - 1 year ago

Nexalin Technology Awarded Key Patent Related to its Gen-3 HALO Clarity™, a Non-Invasive, Frequency-Based Deep-Brain Stimulation Device

Apr 2, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board

Mar 28, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Announces Positive Results of Clinical Study Validating its Gen-2 tACS Device for Reducing Pain Among Veterans with Mild Traumatic Brain Injury at University of California, San Diego

Mar 14, 2024, 8:30 AM EDT - 1 year ago

Nexalin Technology Commences Sales of Gen-2 Neurostimulation Device to New Mental Health Center in Oman Dedicated to Nexalin's Technology

CapitalistInvestor Oct. 11 at 7:38 PM

$NXL Make sure you have ticker VRME on ur watch list. VRME is a verified sleeper. Cash flow ✅ Hidden treasury ✅ Technical breakout loading ✅ Bottomed chart. Minimal downside. Max leverage.

0 · Reply

davis8uni Oct. 11 at 12:33 PM

$BULL $ATON $NXL $XBIO $BIAF

0 · Reply

Modsiu Oct. 11 at 1:05 AM

$SPRB $ZNB $ONMD $BNAI $NXL

0 · Reply

Turgor359 Oct. 10 at 4:03 PM

$NXL 🗑️ will be in the 1-1.1 range next week, the cure for cancer donation business way more profitable than actually curing it, I doubt this runs till early 2026

0 · Reply

trading_momentum_x Oct. 10 at 3:57 PM

$APLT looks good to me, this one is getting a nice breakout and seeing some momentum here and leaning bullish on it. $NXL looks like it is stuck in chop here, this one is a clear avoid to me here.

0 · Reply

JL_TradeZ Oct. 10 at 3:20 PM

$NXL 3.8 nhod 🔥

1 · Reply

Goldwave9 Oct. 10 at 2:17 PM

$NXL not really in the position I would prefer. I think it will have to go lower before it can make big gains. in other words, looking good on the 15 but not so good on the hour.

0 · Reply

Porrotu Oct. 10 at 1:49 PM

$NXL Short at $1.50, held overnight (risky :| ), but paying off. Stop loss at $1.50 now

0 · Reply

davis8uni Oct. 10 at 11:18 AM

$BULL $ATON $NXL $XBIO $BIAF

1 · Reply

Superchuck01 Oct. 9 at 6:29 PM

$NXL Got out yesterday at $2.00 Made mine… Hasta la vista baby…

0 · Reply

davis8uni Oct. 9 at 5:56 PM

$BULL $ATON $NXL $XBIO $BIAF

0 · Reply

Moneymastermind99 Oct. 9 at 5:21 PM

$TGL $NXL $BURU UNDER $1 😈😈🤑🤑🤑

1 · Reply

NewYorkBull Oct. 9 at 4:58 PM

$NXL people are so funny, nothing has changed fundamentally between yesterday and today. yet lots of profit taking. the real winners are going to be in this one for multiple catalysts. they just had an offering back in May and have capital for at least another 18 months.

0 · Reply

DiamondCapital Oct. 9 at 3:26 PM

How to NOT research stocks and ape in😃 FULL TUTORIAL VIDEO Strategy No. 2 Video here: https://x.com/stockpicksnyc/status/1976304806475018667?s=46 Not recommended but not going to lie, sometimes it does really work! Not financial advice. Video is intended for entertainment purposes. $BULL $STFS $SILO $NXL $SCWO NOT RECOMMENDED. NOT FINANCIAL ADVICE. PLEASE DONT DO THIS AND IF SO PROCEED WITH CAUTION USING THIS STRATEGY. NOT FINANCIAL ADVICE OTC listed Pennystocks are highly volatile. Trading or investing in them carries a high degree of risk. They are all speculative companies/plays. Please do your own research before trading/investing in an OTC listed stock and/or consult with a financial advisor. You may lose all of your money. Legal disclaimer link in bio. Not financial advice. Video by @BuffaloFiresideChats

1 · Reply

Goldwave9 Oct. 9 at 2:45 PM

$NXL loaded in PM and looking to 2.19

0 · Reply

Trader1141 Oct. 9 at 1:50 PM

$ANVS $NXL like I said… hopefully you dodnt waste your money here

1 · Reply

Emily_Porter_13 Oct. 9 at 1:43 PM

Momentum Plays: $PCSA Choppy, no clear setup—avoid unless breaks 0.57. $NXL Breaking downtrend on big volume candle; monitor follow-through for potential runner (low float, under $1 watch). $CLSK Strong base breakout with momentum; resistance at 20. (X update: Up ~5% premarket on crypto tailwinds, short interest ~15%, relative volume spiking.)

1 · Reply

NewYorkBull Oct. 9 at 1:11 PM

$NXL give it a few weeks, earnings call towards the end of October as well.

0 · Reply

Trader1141 Oct. 9 at 12:30 PM

$ANVS dont waste your money… $NXL had Alzheimer news yesterday and didnt do much

3 · Reply

SHEEPWOLF Oct. 9 at 11:35 AM

$NXL moving up from that $1.46 call, now $1.55...GOING higher. 🌕🌕🌕🌕🌕🌕🌕🌕🌕🌛

0 · Reply

NewYorkBull Oct. 9 at 11:27 AM

$NXL hardest part of trading is literally just being patient.

0 · Reply

trading_momentum_x Oct. 9 at 9:35 AM

$NXL looks good to me here, this one is trying to break its downtrend with one big breakout candle with huge increase in volume. Let's see if we can get some actual follow through tho in coming days

0 · Reply

Market Cap	22.59M
Revenue (ttm)	170,000.00
Net Income (ttm)	-7.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-4,476.47%
Debt to Equity Ratio	0.00

Volume	1,919,500
Avg Vol	5,339,648
Day's Range	N/A - N/A
Shares Out	17.65M
Stochastic %K	37%
Beta	3.59
Analysts	Strong Sell
Price Target	$4.00